Therapeutic effectiveness of recombinant cancer vaccines is associated with a prevalent T-cell receptor alpha usage by melanoma-specific CD8+ T lymphocytes. (Q45134077)
Jump to navigation
Jump to search
scientific article published in November 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Therapeutic effectiveness of recombinant cancer vaccines is associated with a prevalent T-cell receptor alpha usage by melanoma-specific CD8+ T lymphocytes. |
scientific article published in November 2004 |
Statements
Therapeutic effectiveness of recombinant cancer vaccines is associated with a prevalent T-cell receptor alpha usage by melanoma-specific CD8+ T lymphocytes (English)
Ilaria Marigo
Francesco Del Galdo
Carmela De Santo
Paolo Serafini
Thomas Tüting
Julia Lenz
Gabriella Milan
Vincenzo Bronte
1 November 2004